Articles On Telix Pharmaceuticals (ASX:TLX)

Koala Company (ASX:KOA) ripped out a fairly strong first week on the Australian market after floating on Tuesday, March 31, following an upswing that day with two more bumper jumps to settle ~$4/share into the Easter weekend. Listen to t...

S&P/ASX 200 Health Care Index (ASX: XHJ) shares have tumbled 27% over six months as the sector faces multiple challenges. Blackwattle Large Cap Quality Fund portfolio managers Joe Koh and Elan Miller cite unfavourable currency chang...

It's been a wild ride for this erratic ASX healthcare stock. Telix Pharmaceuticals Ltd (ASX: TLX) surged to $29.72 nearly a year ago, only to crash around 72% to $8.26 in February. In the past month the ASX healthcare stock has clawed i...

The Ides of March weighed down the sector, but green shoots of recovery may make April fools of the naysayers Telix Pharmaceuticals shares led the top end recovery with a 40% gain It’s April – and drug developers with names starting with ‘...

The S&P/ASX 200 Index (ASX: XJO) had a tough month in March due to war breaking out in the Middle East, rising inflation, and higher interest rates. This led to the benchmark index sinking a sizeable 7.8% for the month. Not all shares...

Highlights Healthcare stocks face heightened short-selling activity Sector weakness reflects shifting sentiment and company-specific factors Clinical updates and strategic moves shape outlook across key players Healthcare stocks f...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are charging higher today. Shares in the S&P/ASX 200 Index (ASX: XJO) diagnostic and therapeutic product developer closed yesterday trading for $13.04. In afternoon trade on Tuesday, shares a...

It does not always feel comfortable buying shares when they are down heavily. Prices are falling, headlines are negative, and sentiment is weak.  But in my opinion, this can sometimes be the best time to make a move. A market creat...

Are you looking for ASX shares to buy after this month's market weakness? Well, if you are, let's see what analysts are saying about the popular shares in this article, courtesy of The Bull. Are they buys, holds, or sells? Let's find out:...

China’s NMPA just became the game everyone has to play Audeara cracks into China with NMPA win Big market big upside for companies, but execution decides   For any healthcare company eyeing China, there’s one acronym that controls the ent...

It was a sour end to what has otherwise been a sweet week for ASX investors this Friday. After remaining in red territory all session today, the S&P/ASX 200 Index (ASX: XJO) finished the week with a slight 0.11% loss. As such, we head i...

Putting $20,000 to work in the market is a meaningful step. At that size, I'd be thinking about building a portfolio that can grow through different conditions. For me, that means combining quality, growth, and a bit of resilience. He...

Highlights Analyst confidence rises despite recent weakness Growth-focused sectors draw renewed market attention Volatility continues shaping sentiment across key counters Growth-focused ASX stocks continue to attract attention as...

It's been a rough stretch for some of the most talked-about ASX shares. But here's the twist: while share prices have slid or stalled, broker optimism hasn't. In fact, it's surging. Three ASX shares stand out right now: Mesoblast Ltd (A...

If you are looking to add some ASX 200 stocks to your portfolio this week, it could be worth checking out the two in this article. That's because Bell Potter believes they could be dirt cheap at current levels. Here's what the broker is rec...

Highlights Benchmark index extends its losing streak Resource and banking stocks lead declines Defensive sectors offer limited support The Australian market witnessed extended weakness as multiple sectors faced pressur...

ASX health sector falls 1.85% for the past five days while broader market down  Racura Oncology soars as third and final patient dosed in CPACS Phase I trial  Telix submits new drug application to US FDA for brain cancer imaging agent TLX1...

It's been a wild ride for investors in Telix Pharmaceuticals Ltd (ASX: TLX) shares. The biotech star surged to a high of $29.72 nearly a year ago, only to tumble around 56% to $12.29 at the time of writing. That kind of volatility might...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

The S&P/ASX 200 Index (ASX: XJO) enjoyed another mild recovery day this hump day, adding to yesterday's modest rise. After a brief dip into negative territory this morning, the ASX 200 spent the rest of the day in the green, closing up...

ASX healthcare stocks are a popular option for investors seeking defensive assets with long-term structural growth. These shares can offer portfolio diversification, drive high margins, and some of them have huge potential upside. He...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are racing higher in Wednesday morning trade. At the time of writing the biopharmaceutical company's shares are up 8% to $12.58 a piece. The uptick now means the shares are 11% higher for the y...

Investors caught a break in what was a mildly positive Tuesday session for the S&P/ASX 200 Index (ASX: XJO) and many ASX shares. After starting strong this morning, the ASX 200 took a brief dip into negative territory in afternoon tradi...

Several high-profile ASX shares have taken a beating in recent months. Technology and biotech names have been caught in the market sell-off, with some shares sliding 50% from recent highs. But that weakness has also caught the attention...

At first glance, the Australian share market doesn't look particularly cheap. Even after the recent pullback driven by escalating tensions in the Middle East, the S&P/ASX 200 Index (ASX: XJO) is still sitting not far from record hig...

ASX utilities stock Rivco Australia Ltd (ASX: RIV) is in focus today. The team at Bell Potter have just initiated coverage on it, with a positive outlook.  Company overview Rivco Australia is provides investors with exposure to the A...

Highlights Short interest trends reveal shifting sentiment across several ASX companies Declining bearish positions seen in a few heavily pressured businesses Fresh pessimistic bets emerge in technology, healthcare and servi...

The S&P/ASX 200 Index (ASX: XJO) is out of form on Monday. In afternoon trade, the benchmark index is down 0.5% to 8,573.9 points. Four ASX shares that are falling more than most today are listed below. Here's why they are dropping:...

Highlights Several well-known Australian companies are attracting elevated bearish positioning across the market. Food, technology, healthcare and resource names dominate the latest list. Shifting sentiment highlights how va...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Rudi Filapek-Vandyck An additional news report on the recommendation, valuation, forecast...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are on the slide on Monday morning. At the time of writing, the ASX healthcare stock is down 2.5% to $11.03. Why are Telix Pharmaceuticals shares falling today? Investors have been selling the com...

The Perpetual Ltd (ASX: PPT) share price is in focus after the company announced the sale of its Wealth Management business to Bain Capital for an upfront $500 million, plus potential further payments. What did Perpetual report? Binding de...

The Orica Ltd (ASX: ORI) share price is in focus today after the company announced the settlement of US litigation and a new acquisition in North America. Highlights include resolving the CF Industries dispute for US$169.5 million and movin...

The Lynas Rare Earths Ltd (ASX: LYC) share price is in focus today after the company announced a major supply agreement with the US Department of War, involving US$96 million in rare earth oxide offtake and a US$110/kg floor price for NdPr....

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is in focus after the company announced it has resubmitted its New Drug Application (NDA) to the U.S. FDA for TLX101-Px (Pixclara®), a brain cancer imaging candidate. Telix's resubmissio...

The Meridian Energy Ltd (ASX: MEZ) share price is in focus today after the company released its operating update for February 2026, showing customer growth of 2.1% during the month and a lift in total water inflows for the year to date. Wha...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, March 16, 2026 /PRNewswire/ — Telix Pharma...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

The investment team in charge of Australian Foundation Investment Co Ltd (ASX: AFI) (AFIC) has extensive experience selecting S&P/ASX 200 Index (ASX: XJO) shares to generate income and growth returns. AFIC is the largest and one of...

The S&P/ASX 200 Index (ASX: XJO) was thrust back into negative territory this Thursday, and decisively so, throwing off the optimistic recovery we had been witnessing for much of this week. By the time the markets closed today, the ASX...

Telix Pharmaceuticals Ltd (ASX: TLX) shares could be seriously undervalued and destined to deliver market-beating returns. That's the view of analysts at Bell Potter, who are tipping the radiopharmaceuticals company as an ASX share to buy n...

ASX healthcare stocks have largely struggled over the last 12 months.  The S&P/ASX 200 Health Care Index (ASX: XHJ) is down more than 20% in that span.  The sector has struggled to break out of its multi-year downgrade cycle, w...

Telix Pharmaceuticals Ltd (ASX: TLX) had some big news this week, releasing results showing that its potential prostate cancer drug, TLX-591, was safe to use. It's a significant milestone for the company, which has an established revenu...

Rhythm’s long quest to develop better bowel cancer test starts to reap financial rewards Imugene goes to the well after promising blood cancer trial results Adherium says its asthma monitoring tool reduces hospitalisations Medical diagn...

Broadly speaking, the ASX-listed healthcare sector is struggling to break out of its "multi-year downgrade cycle", according to the team at Wilsons Advisory. But that doesn't mean there aren't bargains to be had, with some shares overso...

Highlights Technology and lithium names lift overall market sentiment. Healthcare developments attract attention in the biotech space. Energy companies face pressure as oil prices retreat. Australian equities staged a...

Highlights Broad market recovery led by mining, technology and healthcare shares Several ASX listed companies draw attention during the rebound Energy and consumer staples sectors move in the opposite direction Austral...

The S&P/ASX 200 Index (ASX: XJO) enjoyed a decisive relief rally this Tuesday, delivering some welcome respite for investors after yesterday's horror-show start to the week. By the time trading wrapped up today, the ASX 200 had gained a...

It’s been a bounce-back day for Australian shares, with yesterday’s bloodbath somewhat pared by +1.5% gains across the day on Trump’s “peace” boasts. It’s not been a slam-dunk green day for every stock, though, with some – including our top...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is back on form and pushing higher. At the time of writing, the benchmark index is up 1.3% to 8,711.9 points. Four ASX shares that are rising more than most today are listed below....